基于医疗机构类型的急性髓系白血病早期死亡率和总生存期
该研究利用美国国家癌症数据库比较2003至2011年间接受首疗程治疗的60738例急性髓系白血病(AML)患者在学术中心与非学术中心的1个月死亡率和长期总生存期(OS)。非学术中心患者的1个月死亡率更高(29% vs 16%),5年OS更低(15% vs 25%)。调整预后协变量后,非学术中心的1个月死亡率(OR 1.52;95%CI 1.46-1.59;P<.0001)和OS仍显著更差。
要点
- 非学术中心AML患者1个月死亡率为29%,学术中心为16%。
- 非学术中心AML患者5年OS为15%,学术中心为25%。
- 调整协变量后,非学术中心1个月死亡率OR为1.52(95%CI 1.46-1.59)。
核心结论
- 在学术中心接受初始治疗与较低的1个月死亡率和较高的长期OS相关。
- 研究潜在原因可能有助于减少这一差异。
研究设计与样本
- 基于美国国家癌症数据库的回顾性队列研究,纳入2003年至2011年间接受首疗程治疗的60738例AML患者,比较学术中心与非学术中心(社区癌症项目、综合社区癌症项目及其他)的结局。
- 采用逻辑回归分析1个月死亡率,采用Cox回归(向后 elimination 法)分析OS。
主要发现
- 学术中心患者与非学术中心患者相比:中位年龄62岁 vs 70岁(P<.0001),少数族裔更多(P<.0001),教育水平更低(P=.005),共病评分更低(P<.0001),收入和保险类型不同(P<.0001),更多接受化疗(P<.0001)和移植(P<.0001)。
- 非学术中心 vs 学术中心:1个月死亡率29% vs 16%(P<.0001),5年OS 15% vs 25%(P<.0001)。
- 调整预后协变量后,非学术中心 vs 学术中心:1个月死亡率OR 1.52(95%CI 1.46-1.59;P<.0001),OS显著更差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cancer health disparities may exist based on the facility type. We aimed to determine the association between the academic status of centers and outcomes of patients with acute myeloid leukemia (AML). Using the National Cancer Data Base, we compared 1-month mortality and long-term overall survival (OS) of 60 738 patients with AML, who received first course treatment between 2003 and 2011 at academic or nonacademic centers (community cancer program, comprehensive community cancer program, and others). Multivariate analysis was done using logistic regression for one-month mortality and Cox regression with backward elimination approach for OS. Patients treated at academic centers differed from those at nonacademic centers in that they were younger with a median age of 62 versus 70 years (P < .0001), more often an ethnic minority (P < .0001), had lower education level (P = .005), lower co-morbidity score (P < .0001), a different income (P < .0001), and insurance profile (P < .0001), and more often received chemotherapy (P < .0001) and transplant (P < .0001). Receipt of care at nonacademic centers was associated with worse 1-month mortality (29% vs. 16%, P < .0001) and 5-year OS (15% vs. 25%; P < .0001). After adjusting for prognostic covariates, the 1-month mortality (odds ratio, 1.52; 95% confidence interval, CI 1.46-1.59; P < .0001) and OS were significantly worse in nonacademic centers, compared to academic centers. Our large database study suggests that the receipt of initial therapy at academic centers is associated with lower 1-month mortality and higher long-term OS. Investigation of the underlying reasons may allow reducing this disparity.
引用
- Bhatt VR, Shostrom V, Giri S, et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am J Hematol. 2017. PMID: 28437868. doi:10.1002/ajh.24767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。